(S)-4-benzyloxycarbonylamino-4-fluorocarbonylbutyric acid tert-butyl ester | 133010-26-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-4-benzyloxycarbonylamino-4-fluorocarbonylbutyric acid tert-butyl ester
• 英文别名: Z-Glu(O-t-Bu)-F；Z-L-Glu(OtBu)-F；tert-butyl (4S)-5-fluoro-5-oxo-4-(phenylmethoxycarbonylamino)pentanoate
• CAS: 133010-26-1
• 化学式: C₁₇H₂₂FNO₅
• 分子量: 339.364
• InChiKey: KCDBNIBRYUHCKZ-ZDUSSCGKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  24
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  81.7
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  L-丙氨酸甲酯盐酸盐 、 (S)-4-benzyloxycarbonylamino-4-fluorocarbonylbutyric acid tert-butyl ester 在 碳酸氢钠 作用下， 以 二氯甲烷 、 水 为溶剂， 以73.2%的产率得到Z-Glu(O-t-Bu)-Ala-OMe
  参考文献：
  名称：

  tert-Butyloxycarbonyl and benzyloxycarbonyl amino acid fluorides. New, stable rapid-acting acylating agents for peptide synthesis

  摘要：

  A new class of rapid-acting acylating agents, alpha-BOC and Z amino acid fluorides are obtained as stable, often crystalline, compounds by treatment of the protected amino acid with cyanuric fluoride.

  DOI：

  10.1021/jo00008a005
• 作为产物：
  描述：

  N-苄氧羰基-L-谷氨酸γ-叔丁酯 在 吡啶 、 三聚氟氰 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 以100%的产率得到(S)-4-benzyloxycarbonylamino-4-fluorocarbonylbutyric acid tert-butyl ester
  参考文献：
  名称：

  Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds

  摘要：

  The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochemical pathways of Plasmodium falciparum . However, it appears that screening directly on the parasite is a more rewarding approach. The "drug to genome to drug" approach consists of testing a small set of structural analogues of a drug acting on human proteins that have plasmodial orthologues. Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis. We synthesized and tested 40 analogues of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth. We discuss the structure-activity relationships, which support the hypothesis that our compounds kill the parasite via inhibition of plasmodial PDE activity. We also prove that antiplasmodial derivatives inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum .

  DOI：

  10.1021/jm1014617

文献信息

• CARPINO, LOUIS A.;MANSOUR, EL-SAYED M. E.;SADAT-AALAEE, DEAN, J. ORG. CHEM., 56,(1991) N, C. 2611-2614
  作者：CARPINO, LOUIS A.、MANSOUR, EL-SAYED M. E.、SADAT-AALAEE, DEAN

  DOI：——

  日期：——
• tert-Butyloxycarbonyl and benzyloxycarbonyl amino acid fluorides. New, stable rapid-acting acylating agents for peptide synthesis
  作者：Louis A. Carpino、El-Sayed M. E. Mansour、Dean Sadat-Aalaee

  DOI：10.1021/jo00008a005

  日期：1991.4

  A new class of rapid-acting acylating agents, alpha-BOC and Z amino acid fluorides are obtained as stable, often crystalline, compounds by treatment of the protected amino acid with cyanuric fluoride.
• Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds
  作者：Terence B. Beghyn、Julie Charton、Florence Leroux、Guillaume Laconde、Arnaud Bourin、Paul Cos、Louis Maes、Benoit Deprez

  DOI：10.1021/jm1014617

  日期：2011.5.12

  The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochemical pathways of Plasmodium falciparum . However, it appears that screening directly on the parasite is a more rewarding approach. The "drug to genome to drug" approach consists of testing a small set of structural analogues of a drug acting on human proteins that have plasmodial orthologues. Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis. We synthesized and tested 40 analogues of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth. We discuss the structure-activity relationships, which support the hypothesis that our compounds kill the parasite via inhibition of plasmodial PDE activity. We also prove that antiplasmodial derivatives inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum .